• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.50% Nasdaq Down2.41%

    More On CANF



    News & Info


    Analyst Coverage



    Can-Fite BioPharma Ltd. (CANF)

    2.55 Down 0.06(2.12%) Jun 27, 4:00PM EDT
    ProfileGet Profile for:
    Can-Fite BioPharma Ltd.
    10 Bareket Street
    Kiryat Matalon
    Petah-Tikva, 4951778
    Israel - Map
    Phone: 972 3 924 1114
    Fax: 972 3 924 9378
    Website: http://www.canfite.co.il

    Index Membership:N/A
    Full Time Employees:8

    Business Summary 

    Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases, as well as sexual dysfunction. It offers CF101, which has completed Phase II/III clinical trials for the treatment of psoriasis; completed Phase II clinical trials for the treatment of rheumatoid arthritis; completed Phase I clinical study for the treatment of osteoarthritis; and completed Phase I study for the treatment of uveitis, as well as is in Phase II clinical trials for the treatment of glaucoma or related syndromes of ocular hypertension. The company also develops CF102 that conducts a Phase II study for treating hepatocellular carcinoma and hepatitis C virus; and CF602, which is in pre-clinical trial for the treatment of sexual dysfunction. Can-Fite BioPharma Ltd. is headquartered in Petah-Tikva, Israel.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Can-Fite BioPharma Ltd.

    Key Executives 
    Prof. Pnina Fishman Ph.D., 67
    Scientific Founder, Chief Exec. Officer and Director
    Mr. Motti Farbstein , 52
    Chief Operating and Financial Officer
    Dr. Ilan Cohn Ph.D., 62
    Co-Founder and Chairman
    Dr. Michael H. Silverman M.D., F.A.C.P.,FACR,
    Medical Director
    Dr. Vibeke Strand M.D., FACP, FACR (USA),
    Sr. Clinical Advisor
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.